Stay updated on Complications of UTI in Dapagliflozin Clinical Trial
Sign up to get notified when there's something new on the Complications of UTI in Dapagliflozin Clinical Trial page.

Latest updates to the Complications of UTI in Dapagliflozin Clinical Trial page
- Check6 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0; the study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedA site-wide NIH notice says the agency is transitioning to use “Super Intelligence” instead of “Artificial Intelligence” and provides updates and FAQs.SummaryDifference1%

- Check20 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error, and its footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check27 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study record details and navigation. This alters how users access the study information by restricting visibility.SummaryDifference15%

- Check69 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a small internal update to the page's revision metadata without changing the visible content.SummaryDifference0.1%

Stay in the know with updates to Complications of UTI in Dapagliflozin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Complications of UTI in Dapagliflozin Clinical Trial page.